Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-5-7
|
pubmed:abstractText |
The levels of extracellular striatal dopamine and glutamate were measured simultaneously in halothane-anaesthetized rats using microdialysis. Unilateral injections of substance P (0.07 nmol) into the substantia nigra, pars reticulata enhanced the levels of dopamine and glutamate in the ipsilateral striatum. Intranigral injections of neurokinin A (0.09 nmol) enhanced the levels of striatal dopamine, and intranigral injections of gamma-aminobutyric acid (300 nmol) or dynorphin A (0.5 nmol) decreased the levels of striatal dopamine, but none of these had any effect on the levels of striatal glutamate. Local perfusion with the dopamine agonists apomorphine (D1/D2), SKF 38393 (D1) or pergolide (D2) (each at 10(5) M) decreased the levels of striatal dopamine and enhanced the levels of striatal glutamate. In unilateral 6-hydroxydopamine-lesioned rats, basal striatal glutamate levels were decreased bilaterally. Furthermore, on the denervated side intranigral substance P stimulation of striatal glutamate levels was enhanced, while on the intact side intranigral substance P stimulation of striatal dopamine and glutamate levels was similar to that seen in normal rats. These findings suggest that striatonigral substance P provides a stimulatory regulation of ipsilateral striatal glutamate release. Furthermore, it is indicated that striatal glutamate release can also be regulated by dopamine terminals.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3,4-Dihydroxyphenylacetic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Glutamates,
http://linkedlifedata.com/resource/pubmed/chemical/Glutamic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxydopamines,
http://linkedlifedata.com/resource/pubmed/chemical/Oxidopamine,
http://linkedlifedata.com/resource/pubmed/chemical/Substance P
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0001-6772
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
140
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
527-37
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1707211-3,4-Dihydroxyphenylacetic Acid,
pubmed-meshheading:1707211-Animals,
pubmed-meshheading:1707211-Corpus Striatum,
pubmed-meshheading:1707211-Denervation,
pubmed-meshheading:1707211-Dopamine,
pubmed-meshheading:1707211-Dopamine Agents,
pubmed-meshheading:1707211-Glutamates,
pubmed-meshheading:1707211-Glutamic Acid,
pubmed-meshheading:1707211-Hydroxydopamines,
pubmed-meshheading:1707211-Male,
pubmed-meshheading:1707211-Oxidopamine,
pubmed-meshheading:1707211-Rats,
pubmed-meshheading:1707211-Rats, Inbred Strains,
pubmed-meshheading:1707211-Substance P,
pubmed-meshheading:1707211-Substantia Nigra
|
pubmed:year |
1990
|
pubmed:articleTitle |
Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
|
pubmed:affiliation |
Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|